- Home
- CHEF vs VKTX Comparison
CHEF vs VKTX Comparison
Compare CHEF & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHEF | VKTX |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CHEF | VKTX |
|---|---|---|
| Price | $85.14 | $27.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $76.33 | ★ $95.86 |
| AVG Volume (30 Days) | 349.8K | ★ 1.8M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.27 | N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $1,301,520,000.00 | N/A |
| Revenue This Year | $8.66 | N/A |
| Revenue Next Year | $7.83 | N/A |
| P/E Ratio | $206.73 | ★ N/A |
| Revenue Growth | ★ 9.11 | N/A |
| 52 Week Low | $53.24 | $22.96 |
| 52 Week High | $83.35 | $43.15 |
Technical Indicators
Market Signals| Indicator | CHEF | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 75.26 | 37.53 |
| Support Level | $57.47 | $25.77 |
| Resistance Level | N/A | $37.23 |
| Average True Range (ATR) | 2.66 | 1.29 |
| MACD | 0.30 | -0.17 |
| Stochastic Oscillator | 99.82 | 7.03 |
Price Performance
Historical ComparisonAbout CHEF The Chefs' Warehouse Inc.
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States, the Middle East and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.